Cart
sales@molnova.com
JNJ-65355394
CAS No. 2230598-99-7
JNJ-65355394( —— )
Catalog No. M35965 CAS No. 2230598-99-7
JNJ-65355394 is an effective O-GlcNAc hydrolase (OGA) inhibitor and an OGA chemical probe.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 265 | In Stock |
|
| 10MG | 377 | In Stock |
|
| 25MG | 610 | In Stock |
|
| 50MG | 798 | In Stock |
|
| 100MG | 1070 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-65355394
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-65355394 is an effective O-GlcNAc hydrolase (OGA) inhibitor and an OGA chemical probe.
-
DescriptionJNJ-65355394 (Compound 28) is an O-GlcNAc hydrolase (OGA) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230598-99-7
-
Formula Weight358.5
-
Molecular FormulaC19H26N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=1SC(NC(C)=O)=NC1)N2C[C@@H](CC=3C=C(C)N=C(C)C3)CCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. José Manuel BARTOLOMé-NEBREDA, et al. Monocyclic oga inhibitor compounds. Patent WO2018109202A1.
molnova catalog
related products
-
Lumiliximab
Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases.
-
IMM-H007
IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression.
-
Tylosin
Tylosin (Fradizine; Tylocine; Tylosin A) is a broad spectrum antibiotic against Gram-positive organisms and a limited range of Gram-negative organisms.
